A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes

Summary

The main purpose of this study, performed under the master protocol W8M-MC-CWMM (NCT06143956), is to evaluate the effects of treatment with LY3549492 compared to placebo in adult participants with obesity or who are overweight with type 2 diabetes. Participation in the study will last about 11 months.

Timeline

Start

2025-06-19

Primary completion

2025-07-29

Completion

2025-07-29

Outcome

Outcome not reported

Stopped (Business): “Study terminated for strategic business reasons”

Drugs

Indications